Broad targeting of angiogenesis for cancer prevention and therapy Z Wang, C Dabrosin, X Yin, MM Fuster, A Arreola, WK Rathmell, ... Seminars in cancer biology 35, S224-S243, 2015 | 520 | 2015 |
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer KGK Deepak, R Vempati, GP Nagaraju, VR Dasari, S Nagini, DN Rao, ... Pharmacological research 153, 104683, 2020 | 351 | 2020 |
Reproductive regulators in decapod crustaceans: an overview GPC Nagaraju Journal of Experimental Biology 214 (1), 3-16, 2011 | 344 | 2011 |
Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 308 | 2015 |
Is methyl farnesoate a crustacean hormone? GPC Nagaraju Aquaculture 272 (1-4), 39-54, 2007 | 220 | 2007 |
Matrix metalloproteinases: their functional role in lung cancer N Merchant, GP Nagaraju, B Rajitha, S Lammata, KK Jella, ZS Buchwald, ... Carcinogenesis 38 (8), 766-780, 2017 | 191 | 2017 |
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj, P Kuppusamy, ... Autophagy 13 (8), 1386-1403, 2017 | 174 | 2017 |
Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis GP Nagaraju, R Dontula, BF El-Rayes, SS Lakka Carcinogenesis 35 (5), 967-973, 2014 | 157 | 2014 |
Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis GP Nagaraju, PV Bramhachari, G Raghu, BF El-Rayes Cancer letters 366 (1), 11-18, 2015 | 133 | 2015 |
FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells LT Taliaferro-Smith, E Oberlick, T Liu, T McGlothen, T Alcaide, R Tobin, ... Oncotarget 6 (7), 4757, 2015 | 128 | 2015 |
Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients B Dariya, GP Nagaraju Cytokine & growth factor reviews 53, 43-52, 2020 | 118 | 2020 |
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3 PN Ganji, W Park, J Wen, H Mahaseth, J Landry, AB Farris, F Willingham, ... Angiogenesis 16, 903-917, 2013 | 116 | 2013 |
The impact of curcumin on breast cancer GP Nagaraju, S Aliya, SF Zafar, R Basha, R Diaz, BF El-Rayes Integrative Biology 4 (9), 996-1007, 2012 | 112 | 2012 |
Lifelong running reduces oxidative stress and degenerative changes in the testes of mice S Chigurupati, TG Son, DH Hyun, JD Lathia, MR Mughal, J Savell, SC Li, ... Journal of Endocrinology 199 (2), 333-341, 2008 | 110 | 2008 |
Epigenetics in hepatocellular carcinoma GP Nagaraju, B Dariya, P Kasa, S Peela, BF El-Rayes Seminars in cancer biology 86, 622-632, 2022 | 108 | 2022 |
Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer R Vadde, S Vemula, R Jinka, N Merchant, PV Bramhachari, GP Nagaraju Critical reviews in oncology/hematology 113, 22-27, 2017 | 108 | 2017 |
Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer GP Nagaraju, TE Long, W Park, JC Landry, LT Taliaferro‐Smith, AB Farris, ... Molecular carcinogenesis 54 (10), 1147-1158, 2015 | 102 | 2015 |
Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases GP Nagaraju, SF Zafar, BF El-Rayes Nutrition reviews 71 (8), 562-572, 2013 | 102 | 2013 |
Anti-cancer role of SPARC, an inhibitor of adipogenesis GPC Nagaraju, D Sharma Cancer treatment reviews 37 (7), 559-566, 2011 | 101 | 2011 |
Advanced glycation end products in diabetes, cancer and phytochemical therapy B Dariya, GP Nagaraju Drug Discovery Today 25 (9), 1614-1623, 2020 | 100 | 2020 |